YU110892A - Stabilne soli(+)-(1s,2r)-2-{[n-(2-hidroksiamino-2-oksoetil)-n-metilamino]karbonil}-cikloheksan-1-karbonske kiseline, postupak za njihovo dobijanje i preparati koji ih sadrže - Google Patents

Stabilne soli(+)-(1s,2r)-2-{[n-(2-hidroksiamino-2-oksoetil)-n-metilamino]karbonil}-cikloheksan-1-karbonske kiseline, postupak za njihovo dobijanje i preparati koji ih sadrže

Info

Publication number
YU110892A
YU110892A YU110892A YU110892A YU110892A YU 110892 A YU110892 A YU 110892A YU 110892 A YU110892 A YU 110892A YU 110892 A YU110892 A YU 110892A YU 110892 A YU110892 A YU 110892A
Authority
YU
Yugoslavia
Prior art keywords
hydroxyamino
oxoethyl
methylamino
cyclohexane
carbonyl
Prior art date
Application number
YU110892A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
R. Giorgi
A. Subbisi
L. Turbanti
Original Assignee
Laboratori Guidotti Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratori Guidotti Spa filed Critical Laboratori Guidotti Spa
Publication of YU110892A publication Critical patent/YU110892A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
YU110892A 1991-12-23 1992-12-23 Stabilne soli(+)-(1s,2r)-2-{[n-(2-hidroksiamino-2-oksoetil)-n-metilamino]karbonil}-cikloheksan-1-karbonske kiseline, postupak za njihovo dobijanje i preparati koji ih sadrže YU110892A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI913448A IT1252708B (it) 1991-12-23 1991-12-23 Sali stabili dell'acido (+)-(1r,2s)-2((n-(2-idrossilammino-2-ossoetil)-n-metilammino)carbonil)cicloesan-1-carbossilico,ad attivita' ace inibitrice, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.

Publications (1)

Publication Number Publication Date
YU110892A true YU110892A (sh) 1996-01-08

Family

ID=11361409

Family Applications (1)

Application Number Title Priority Date Filing Date
YU110892A YU110892A (sh) 1991-12-23 1992-12-23 Stabilne soli(+)-(1s,2r)-2-{[n-(2-hidroksiamino-2-oksoetil)-n-metilamino]karbonil}-cikloheksan-1-karbonske kiseline, postupak za njihovo dobijanje i preparati koji ih sadrže

Country Status (26)

Country Link
EP (1) EP0575572A1 (fr)
JP (1) JPH06506002A (fr)
CN (1) CN1079474A (fr)
AU (1) AU657591B2 (fr)
BG (1) BG98050A (fr)
BR (1) BR9205652A (fr)
CA (1) CA2104372A1 (fr)
CZ (1) CZ379692A3 (fr)
EE (1) EE9400006A (fr)
FI (1) FI933685A0 (fr)
HR (1) HRP921454A2 (fr)
HU (1) HUT69287A (fr)
IT (1) IT1252708B (fr)
LV (1) LV10426B (fr)
MA (1) MA22749A1 (fr)
MX (1) MX9207543A (fr)
NZ (1) NZ245547A (fr)
PL (1) PL169086B1 (fr)
PT (1) PT101156A (fr)
RU (1) RU2079489C1 (fr)
SI (1) SI9200409A (fr)
SK (1) SK379692A3 (fr)
TN (1) TNSN92117A1 (fr)
WO (1) WO1993013056A1 (fr)
YU (1) YU110892A (fr)
ZA (1) ZA9210004B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264860B1 (it) * 1993-06-21 1996-10-17 Guidotti & C Spa Labor Derivati di acidi cis- e trans-2(((2-(isdrossiammino)-2-ossoetil)- alchilammino)carbonil)cicloesancarbossilici
US5639746A (en) * 1994-12-29 1997-06-17 The Procter & Gamble Company Hydroxamic acid-containing inhibitors of matrix metalloproteases
FR2817241B1 (fr) 2000-11-30 2003-03-07 Cebal Tube aluminium avec embout secable
CN101516191A (zh) * 2006-09-28 2009-08-26 默克公司 Saha的胺碱盐和其多晶型物
CN114845603B (zh) 2020-04-27 2025-01-24 卡特-霍夫曼有限责任公司 用于柜的门移动系统

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1224627B (it) * 1988-04-12 1990-10-04 Guidotti & C Spa Labor Ammidi di acidi ciclometilen_1,2_dicarbossilici adattivita' terapeutica, procedimenti per la loro preparazione e composizioni farmaceutiche che le contengono.

Also Published As

Publication number Publication date
JPH06506002A (ja) 1994-07-07
MX9207543A (es) 1993-08-01
AU657591B2 (en) 1995-03-16
AU3087192A (en) 1993-07-28
SI9200409A (en) 1993-09-30
CN1079474A (zh) 1993-12-15
ITMI913448A1 (it) 1993-06-23
RU2079489C1 (ru) 1997-05-20
MA22749A1 (fr) 1993-07-01
NZ245547A (en) 1995-12-21
LV10426B (en) 1995-08-20
FI933685L (fi) 1993-08-20
FI933685A7 (fi) 1993-08-20
CA2104372A1 (fr) 1993-06-24
EP0575572A1 (fr) 1993-12-29
ZA9210004B (en) 1993-12-13
PL297118A1 (en) 1993-09-06
HU9302389D0 (en) 1993-11-29
PT101156A (pt) 1994-06-30
SK379692A3 (en) 1995-04-12
FI933685A0 (fi) 1993-08-20
ITMI913448A0 (it) 1991-12-23
BG98050A (bg) 1994-04-29
BR9205652A (pt) 1994-05-03
HRP921454A2 (en) 1995-02-28
WO1993013056A1 (fr) 1993-07-08
LV10426A (lv) 1995-02-20
EE9400006A (et) 1995-12-15
CZ379692A3 (en) 1993-09-15
HUT69287A (en) 1995-09-28
IT1252708B (it) 1995-06-26
PL169086B1 (pl) 1996-05-31
TNSN92117A1 (fr) 1993-06-08

Similar Documents

Publication Publication Date Title
EA200000682A1 (ru) Новые ацилгуанидиновые производные в качестве ингибиторов резорбции костной ткани и антагонистов витронектиновых рецепторов
FR2800375B1 (fr) Derives tricycliques d'acide pyrazolecarboxylique, leur preparation, les compositions pharmaceutiques en contenant
HUT55011A (en) Process for producing imidazolylalkenoic acids and pharmaceutical compositions comprising such compounds as active ingredient
BR9713182A (pt) Amidas de ácido fosfìnico como inibidores de metalo protease de matriz
RU94041210A (ru) [/бензодиоксан, бензофуран или бензопиран/-алкиламино]-алкилзамещенные гуанидины в качестве селективных сосудосуживающих средств, способ их получения, промежуточное для них, композиция и способ ее получения
KR900015729A (ko) 흥분성 아미노산 길항제
EA200401108A1 (ru) Соли толтеродина
FR2688499B1 (fr) Procede de preparation de la beta-phenylisoserine et de ses analogues.
TNSN90021A1 (fr) Procede de preparation de tetrahydroimidazo (1,4) benzodiazepin -2- thiones antivirales
IL144725A0 (en) Novel guanidine derivatives as inhibitors of cell adhesion
EP0351385A3 (fr) Dérivés d'amidino et de guanidino
ATE233246T1 (de) Hydantoinderivate als zwischenprodukte für pharmazeutische wirkstoffe
MX2022008334A (es) Nuevo compuesto, metodo de preparacion del mismo y uso del mismo.
PT823909E (pt) Nova quimica heterociclica
KR940005615A (ko) 시클로헵트이미다졸 유도체, 그의 제조방법 및 이 화합물을 함유하는 치료제
ITMI922742A1 (it) Composti ad attivita' terapeutica utili per il trattamento di malattie connesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
MX9207543A (es) Sales estables de acido (+)-(1s,2r)-[[b.(2-hidroxilamino-2-oxoetil)-n-metilamino]carbonil]cicl ohexan-1-carboxilico, procedimiento para su preparacion, y composiciones farmaceuticas que las contienen
FR2676059A1 (fr) Nouveaux derives de peptides utilisables comme inhibiteurs de collagenases bacteriennes.
RU93052414A (ru) Стабильные соли (+)-(1s, 2r)-2-[[n-(2-гидроксиамино-2-оксоэтил)-n-метиламино]карбонил]-циклогексан-1-карбоновой кислоты, способ их получения и фармацевтические композиции, содержащие их
DE3370625D1 (en) Benzhydrylpiperazine derivatives, process for their preparation and pharmaceutical compositions containing them
MX9707673A (es) Derivados de ureido biologicamente activos, eficaces en el tratamiento de la esclerosis multiple.
NO932982L (no) Stabile salter av (+)-(1s,2r)-2-((n-(2-hydroksylamino-2-oksoetyl)-n-metylamino)karbonyl)cykloheksan-1-karboksylsyreog fremgangsmaate for fremstilling derav og farmasoeytiske sammensetninger som inneholder disse
GB1337290A (en) Aromatic sulphamoyl compounds process for their manufacture and compositions containing them
CA2241788A1 (fr) Nouveaux derives de n-(arylsulfonyl)aminoacides, leur procede de preparation et compositions pharmaceutiques en contenant
JO1734B1 (en) New peptide compounds that are symmetric with electronic distribution of molecules